Clinical Trial of Comparative Study of GB221 Pharmacokinetics
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Coprelotamab Injection|DRUG: Trastuzumab Injection
Sponsor: Genor Biopharma Co., Ltd.